Literature DB >> 15665736

Superoxide potentiates NF-kappaB activation and modulates endotoxin-induced cytokine production in alveolar macrophages.

Michael M Ndengele1, Carolina Muscoli, Zhi Qiang Wang, Timothy M Doyle, George M Matuschak, Daniela Salvemini.   

Abstract

Gram-negative bacterial infection predisposes to the development of shock and acute lung injury with multiple organ dysfunction in the critically ill. Although overexpression of proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-1beta, IL-6, IL-8, and other mediators is causally implicated in the pathogenesis of shock and lung injury, the underlying mechanisms following cellular exposure to gram-negative endotoxin remain unclear. De novo generation of reactive oxygen species (ROS) by monocytes/macrophages in particular has been proposed as a pivotal regulatory mechanism by which enhanced transactivation of redox-sensitive genes culminates in augmented cytokine expression within the lower respiratory tract. Here we sought to characterize the mechanism of action of a synthetic, nonpeptide, low-molecular-weight, Mn-containing superoxide dismutase mimetic (SODm), M40403, in modulating E. coli lipopolysaccharide serotype 0111:B4 (LPS)-induced cytokine production by cultured rat alveolar macrophages. Intracellular superoxide (O2) ion generation was measured using hydroethidine (HE) dye, and the dose-dependent effects of M40403 on TNF-alpha and IL-6 biosynthesis by ELISAs. Upstream redox-sensitive signaling events involving the pleiotropic transcription factor NF-kappaB were determined in nuclear extracts by electrophoretic mobility shift assays (EMSAs) and p65 subunit Western blot. The levels of the cytosolic inhibitory protein IkappaB-alpha were also assessed by Western analysis. We found that M40403 potently suppressed the production of superoxide, TNF-alpha, and IL-6 in LPS-stimulated alveolar macrophages, suggesting a key role for superoxide in endotoxin-induced cytokine production in the distal air spaces. In addition, M40403 decreased E. coli LPS-induced activation of NF-kappaB, and this effect was associated with modest suppression of cytoplasmic IkappaB-alpha degradation. Together, these results suggest that removal of superoxide by M40403 inhibits endotoxin-induced production of TNF-alpha and IL-6 in alveolar macrophages by a mechanism involving suppression of redox-sensitive NF-kappaB transactivation or signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665736     DOI: 10.1097/01.shk.0000144130.36771.d6

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  30 in total

1.  Spinal ceramide modulates the development of morphine antinociceptive tolerance via peroxynitrite-mediated nitroxidative stress and neuroimmune activation.

Authors:  Michael M Ndengele; Salvatore Cuzzocrea; Emanuela Masini; M Cristina Vinci; Emanuela Esposito; Carolina Muscoli; Daniela Nicoleta Petrusca; Vincenzo Mollace; Emanuela Mazzon; Dechun Li; Irina Petrache; George M Matuschak; Daniela Salvemini
Journal:  J Pharmacol Exp Ther       Date:  2008-11-25       Impact factor: 4.030

2.  Acute hypoxia decreases E. coli LPS-induced cytokine production and NF-kappaB activation in alveolar macrophages.

Authors:  George M Matuschak; Ravi Nayak; Timothy M Doyle; Andrew J Lechner
Journal:  Respir Physiol Neurobiol       Date:  2010-05-12       Impact factor: 1.931

3.  Aldose reductase inhibition suppresses the expression of Th2 cytokines and airway inflammation in ovalbumin-induced asthma in mice.

Authors:  Umesh C S Yadav; Amarjit S Naura; Leopoldo Aguilera-Aguirre; Kota V Ramana; Istvan Boldogh; Sanjiv Sur; Hamid A Boulares; Satish K Srivastava
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

4.  Pyrrolidine dithiocarbamate inhibits superoxide anion-induced pain and inflammation in the paw skin and spinal cord by targeting NF-κB and oxidative stress.

Authors:  Felipe A Pinho-Ribeiro; Victor Fattori; Ana C Zarpelon; Sergio M Borghi; Larissa Staurengo-Ferrari; Thacyana T Carvalho; Jose C Alves-Filho; Fernando Q Cunha; Thiago M Cunha; Rubia Casagrande; Waldiceu A Verri
Journal:  Inflammopharmacology       Date:  2016-05-09       Impact factor: 4.473

5.  The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injury.

Authors:  Gokulakrishnan Seshadri; Jay C Sy; Milton Brown; Sergey Dikalov; Stephen C Yang; Niren Murthy; Michael E Davis
Journal:  Biomaterials       Date:  2009-11-03       Impact factor: 12.479

6.  Carrageenan-induced NFkappaB activation depends on distinct pathways mediated by reactive oxygen species and Hsp27 or by Bcl10.

Authors:  Sumit Bhattacharyya; Pradeep K Dudeja; Joanne K Tobacman
Journal:  Biochim Biophys Acta       Date:  2008-04-11

7.  Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways.

Authors:  Ines Batinić-Haberle; Michael M Ndengele; Salvatore Cuzzocrea; Júlio S Rebouças; Ivan Spasojević; Daniela Salvemini
Journal:  Free Radic Biol Med       Date:  2008-10-17       Impact factor: 7.376

8.  Involvement of nitric oxide in a rat model of carrageenin-induced pleurisy.

Authors:  Masahiro Iwata; Shigeyuki Suzuki; Yuji Asai; Takayuki Inoue; Kenji Takagi
Journal:  Mediators Inflamm       Date:  2010-06-02       Impact factor: 4.711

9.  ROS, Hsp27, and IKKbeta mediate dextran sodium sulfate (DSS) activation of IkappaBa, NFkappaB, and IL-8.

Authors:  Sumit Bhattacharyya; Pradeep K Dudeja; Joanne K Tobacman
Journal:  Inflamm Bowel Dis       Date:  2009-05       Impact factor: 5.325

10.  Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Michael M Ndengele; Vincenzo Mollace; Frank Porreca; Francesca Fabrizi; Emanuela Esposito; Emanuela Masini; George M Matuschak; Daniela Salvemini
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.